about
Autologous cord blood therapy for infantile cerebral palsy: from bench to bedside.Viability and functional capacity after thawing of hematopoietic progenitor cells cryopreserved at a cord blood stem cell bank in Colombia.Transplantation immunology: solid organ and bone marrow.Biosafety assessment of site-directed transgene integration in human umbilical cord-lining cells.Inefficient dystrophin expression after cord blood transplantation in Duchenne muscular dystrophy.Human placenta and chorion: potential additional sources of hematopoietic stem cells for transplantation.Factors That Influence a Mother's Willingness to Preserve Umbilical Cord Blood: A Survey of 5120 Chinese MothersSafety of Allogeneic Umbilical Cord Blood Stem Cells Therapy in Patients with Severe Cerebral Palsy: A Retrospective StudySafety and feasibility of countering neurological impairment by intravenous administration of autologous cord blood in cerebral palsy.Qualitative and quantitative cell recovery in umbilical cord blood processed by two automated devices in routine cord blood banking: a comparative studyUmbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double-blind, randomized, placebo-controlled trialCellular transplant therapies for globoid cell leukodystrophy: Preclinical and clinical observationsReview of chronic graft-versus-host disease in children after allogeneic stem cell transplantation: nursing perspective.Stem cell therapy for neonatal brain injury: perspectives and challenges.Transplantation of umbilical cord-derived mesenchymal stem cells as a novel strategy to protect the central nervous system: technical aspects, preclinical studies, and clinical perspectives.Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.Implication of cord blood for cell-based therapy in refractory childhood diseases.Transient Tcf3 Gene Repression by TALE-Transcription Factor Targeting.Proliferation extent of CD34+ cells as a key parameter to maximize megakaryocytic differentiation of umbilical cord blood-derived hematopoietic stem/progenitor cells in a two-stage culture protocol.Developments in Hematopoietic Stem Cell Expansion and Gene Editing Technologies.3-Dimensional nano-fibre scaffold for ex vivo expansion of cord blood haematopoietic stem cells.The role of policies and networks in development of cord blood usage in China.Stem Cell Banking for Regenerative and Personalized Medicine.
P2860
Q30574180-270A3A39-E89A-474F-98D7-424EDE9F0520Q33452165-C914C358-8EC0-4E01-9979-279A5AAB4DA2Q33803804-B43397EF-44C7-4EDB-9A1C-CCB690F4D10DQ34025078-21321615-2F30-42A0-839B-D364AE884117Q34249466-74AAAFA6-B236-44B5-BDC9-21B7F63DAFDBQ35699176-1369CEDB-325B-45FE-A91E-9F420B57834CQ35864326-1DF81770-F104-4EC2-8834-A7D0EF904180Q35876709-5FC98591-90DD-40CB-A289-A75520B1AEA7Q36013774-289AC90D-E032-4FC7-ACA3-810E278D1A95Q37059231-556B80F9-9EA7-4A8A-9FE6-386E1202D7E1Q37098276-A3AF70DE-4391-41FE-BF13-7344E76D8905Q37265581-D1BF4A94-CEAD-4A45-8EDA-845FA7306738Q37788879-FAA40A6E-7F39-476E-9162-1866477F4859Q37967608-2AC92B2F-9BCF-4DE7-AA35-6B04DD733C6DQ37995017-3516F5AC-7710-44CC-AB61-CDED406EA70AQ38006433-4BE495AA-CB14-4885-888A-726556AF1793Q38214093-2859A781-2B8E-4086-BA22-094EF8B96E4BQ38758515-3E4CDF8D-3B2F-4AD7-B6C0-C69A7C031851Q42210360-3C0E238B-652B-4300-AB4B-5C0B728208B8Q47438268-5C33A80B-B852-4B26-B916-962804FFAB9BQ47950333-1F7FAB16-9D41-4FDF-87B9-3CCE310AC9ADQ49617833-C0BD7A1A-1398-465D-96F1-DF4BF5E2D709Q51301197-0EFCEEF8-0661-4195-B2BC-EB2533B3FCE0
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Update on umbilical cord blood transplantation.
@en
type
label
Update on umbilical cord blood transplantation.
@en
prefLabel
Update on umbilical cord blood transplantation.
@en
P2860
P1476
Update on umbilical cord blood transplantation.
@en
P2093
Joanne Kurtzberg
P2860
P356
10.1097/MOP.0B013E32832130BC
P577
2009-02-01T00:00:00Z